Age-Related Cognitive Decline and Prevalence of Mild Cognitive Impairment in the Iwaki Health Promotion Project

Abstract

Background: The Iwaki Health Promotion Project (IHPP) is a community-based study for the prevention of lifestyle-related diseases and improvement of quality of life. Objective: Between 2014 and 2017, a total of 4,442 Iwaki town residents from 19 to 93 years of age participated in annual surveys to clarify the natural course of age-related cognitive decline and mild cognitive impairment (MCI). Methods: Modified OLD and SED-11Q questionnaires, MMSE, Logical Memory II, educational history, and APOE genotypes were examined at the first screening. MCI and dementia were diagnosed at the second examination by detailed neurological examination, CDR, and MRI, and followed for 3 years. Spline regression analyses based on a linear mixed model was adopted for statistical analysis. Results: MMSE scores declined with age from 55 to 64 years. There was also interaction between levels of education and ages. At the second examination, 56 MCI and 5 dementia patients were identified. None of the MCI cases progressed to dementia during the 3 years. During follow-up examinations, 13 cases showed improved MMSE scores (0.95 point/year), 5 remained stable, and 7 deteriorated (–0.83 point/year). Five cases showed improved CDR-SOB scores (–0.28 point/year), 9 remained stable, and 6 deteriorated (0.3 point/year). Conclusion: IHPP revealed that age- and education-related cognitive decline began and advanced from 55 years of age. The prevalence of MCI and dementia was estimated to be 5.9%in the Iwaki town cohort over 60 yeas of age. About 30%of MCI cases showed progression of cognitive decline.

Global cognitive function is associated with sex, educational level, occupation type, and speech recognition rate in older Chinese adults: a single-center, prospective, cross-sectional study

“…Consistent with a Brazilian community sample, education also did not have an important effect on memory registration [38]. However, overall MMSE scores are highly dependent on educational level: low education levels may affect the understanding of MMSE tests [39][40][41]. Furthermore, with increasing educational duration, the levels of MMSE scores increase.…”

Prevalence, risk factors and effectiveness of falls prevention interventions for adults living with Mild Cognitive Impairment in the community: A systematic review and meta-analysis

“…Studies eligible to be included in this review were required to meet the following criteria: Population: Adults 50 years or older with Mild Cognitive Impairment (at least 50% of the sample aged ≥ 50 years). In a study by Nakahata et al, 18 age and education related cognitive decline began and advanced from age 55 years. A younger age (50 years or more) was used to ensure all relevant articles available for people aging with Mild Cognitive Impairment were included.…”

Cognitive impairment does not impact sacral neuromodulation implant rates for overactive bladder

“…16 Multiple community prevalence studies of cognitive impairment include patients starting at age 55, [17][18][19] and prior study has suggested age-related cognitive decline begins and advances after age 55. 20 Patient demographics, comorbidities, CI diagnoses, use of OAB medication and/or onabotulinum toxin, and SNM procedure details were collected. A patient was categorized as having cognitive impairment if they had any diagnosis code for dementia or MCI, or if the patient had an active prescription for a medication that is primarily used to treat dementia (donepezil, galantamine, rivastigmine, or memantine).…”

“…Although age 60 years or more is considered by the World Health Organization as “older,” 15 we used age 55 years as the lower limit for inclusion criteria to capture patients who may have earlier onset cognitive impairment and/or received a diagnosis during their follow‐up period after implantation 16 . Multiple community prevalence studies of cognitive impairment include patients starting at age 55, 17–19 and prior study has suggested age‐related cognitive decline begins and advances after age 55 20 …”